FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

KIORA PHARMACEUTICALS, INC.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2021-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/5465a2c1-5ce0-4303-8d11-ea6ef2aee87e

Reported value

$6.610M{"amount": 6610492, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
KIORA PHARMACEUTICALS, INC.
Metric
cash_and_equivalents
Period
as of 2021-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001104659-21-065128 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T13:10:39.720048+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001372514/cash-and-equivalents/2021-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.